Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

This grant opportunity, IGNITE (R61/R33), supports initial translational efforts for neurotherapeutic agent characterization and in vivo efficacy studies. It aims to nurture innovation in neurotherapeutics, but clinical trials are not allowed under this funding opportunity.